7 Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma

8 Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience

9 Primary Pulmonary Malignant Melanoma Found While Evaluating New Onset Cough: A Case Presentation and Literature Review

10 Radiotherapy for Melanoma: More than DNA Damage

11 Facebook Intervention for Young-Onset Melanoma Patients and Their Family Members: Pilot and Feasibility Study

12 Social Media as a Platform for Information and Support for Melanoma Patients: Analysis of Melanoma Facebook Groups and Pages

13 BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

14 Biologically synthesized green gold nanoparticles from Siberian ginseng induce growth-inhibitory effect on melanoma cells (B16)

15 Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.

16 Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

17 Vitamin D receptors (VDR), hydroxylases CYP27B1 and CYP24A1 and retinoid-related orphan receptors (ROR) level in human uveal tract and ocular melanoma with different melanization levels

18 Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

19 Polyethylenimine and sodium cholate-modified ethosomes complex as multidrug carrier for the treatment of melanoma through transdermal delivery.

20 Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous Melanoma

21 Photodynamic therapy using zinc phthalocyanine in low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.

22 Integrated analyses identify potential prognostic markers for uveal melanoma.

23 Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.

24 Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.

25 Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells

26 [Potential of Using Vitamin D as an Adjuvant Treatment of Malignant Melanoma].

27 An In-Vitro Assay Estimating Changes in Melanin Content of Melanoma Cells due to Ultra-Dilute, Potentized Preparations.

28 An outreach telephone program for advanced melanoma supportive care: Acceptability and feasibility.

29 The Pathogenesis and Clinical Management of Cutaneous Melanoma: An Evidence-Based Review.

30 Cigarette Smoking and the Risk of Cutaneous Melanoma: A Case-Control Study.

31 Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells.

32 [Hepatic epithelioid angiomyolipoma/PEComa and focal nodular hyperplasia in a patient with a previous history of cutaneous melanoma].

33 Combinatorial Discovery of Defined Substrates That Promote a Stem Cell State in Malignant Melanoma

34 Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients

35 The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review.

36 TRIM59 loss in M2 macrophages promotes melanoma migration and invasion by upregulating MMP-9 and Madcam1.

37 Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.

38 BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation.

39 Skin delivery of resveratrol encapsulated lipidic formulation for melanoma chemoprevention.

40 Reduction of postoperative lymphorrhoea in patients undergoing radical lymphadenectomy for stage III melanoma: prospective study using collagen-fibrin patches.

41 Photothermal therapy mediated by phase-transformation nanoparticles facilitates delivery of anti-PD1 antibody and synergizes with antitumor immunotherapy for melanoma.

42 Topological Tumor Graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology.

43 Spleen melanomacrophage centers response of Nile tilapia during Aeromanas hydrophila and Mycobacterium marinum infections.

44 Microscopic melanoma detection and classification: A framework of pixel-based fusion and multilevel features reduction.

45 Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.

46 Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.

47 Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma.

48 Knockdown of circ_0084043 suppresses the development of human melanoma cells through miR-429/tribbles homolog 2 axis and Wnt/β-catenin pathway.

49 Assessment of climate change impact on the malaria vector Anopheles hyrcanus, West Nile disease, and incidence of melanoma in the Vojvodina Province (Serbia) using data from a regional climate model.

50 Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong.

51 Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma

52 Atypical Presentations and Management of Endocrine and Hepatic Immune-Related Adverse Events From Adjuvant Immune Checkpoint Inhibitor Therapy in Stage III Resected Melanoma.

53 Dormant tumor cells interact with memory CD8 T cells in RET transgenic mouse melanoma model.

54 Brafv600e Mutation As A Prognostic Factor In Cutaneous Melanoma Patients.

55 CM-Score: a validated scoring system to predict germline mutations in melanoma families from Northern Europe.

56 Internal Pathology Review of Invasive Melanoma: An Academic Institution Experience

57 The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma.

58 Metalloproteinases Suppression Driven by the Curcumin Analog DM-1 Modulates Invasion in BRAF-Resistant Melanomas.

59 Murine osteoclastogenesis suppression using conditioned media produced by melanoma or activated and non-activated Jurkat-E6 cells.

60 Deregulation of cell growth and apoptosis in UV-induced melanomagenesis.

61 The Susceptibility of Human Melanoma Cells to Infection with the Leningrad-16 Vaccine Strain of Measles Virus.

62 The suppressive effect of dabrafenib, a therapeutic agent for metastatic melanoma, in IgE-mediated allergic inflammation.

63 Corrigendum to “Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells” (Biochemical Pharmacology (2015) 93(3) (290–304), (S0006295214006996), (10.1016/j.bcp.2014.12.003))

64 [Characteristics of CMR Appearance in a Case of Cardiac Metastatic Melanoma].

65 Data analysis of PD-1 antibody in the treatment of melanoma patients.

66 Assessment of Ploy Dopamine Coated Fe3O4 Nanoparticles for Melanoma (B16-F10 and A-375) Cells Detection.

67 Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected V600-Mutant Stage III Melanoma.

68 Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.

69 Skin Lesion Analysis towards Melanoma Detection Using Deep Learning Network

70 Curcumin induce DNA damage and apoptosis through generation of reactive oxygen species and reducing mitochondrial membrane potential in melanoma cancer cells

71 mir-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating adam9 and vegf-a

72 single sternal metastasis due to malignant melanoma with unexpected long-term survival: a case report

73 effect of oncolytic echo-7 virus strain rigvir on uveal melanoma cell lines

74 seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma

75 corrigendum to “antimetastatic potentials of dioscorea nipponica on melanoma in vitro and in vivo”

76 challenges in diagnosis and treatment of a cervical spinal cord injury patient with melanoma, adenocarcinoma, and hepatic and osteolytic metastases: need to implement strategies for prevention and early detection of cancer in spinal cord injury patients

77 chromomycin a2 induces autophagy in melanoma cells

78 emergency surgery for metastatic melanoma

79 primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization

80 a case of melanoma in xeroderma pigmentosum

81 metastatic melanoma to the bladder: case report and review of the literature

82 “unsteady gait”: an uncommon presentation and course of malignant melanoma in terminal ileum—a case report and review of literature

83 metastatic cutaneous melanoma of the gallbladder

84 p16ink4a expression and absence of activated b-raf are independent predictors of chemosensitivity in melanoma tumors

85 inoculation site from a cutaneous melanoma patient treated with an allogeneic therapeutic vaccine: a case report

86 identification of an immune-related signature for the prognosis of uveal melanoma

87 anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines – in vitro studies

88 the use of strontium-90 beta radiotherapy as adjuvant treatment for conjunctival melanoma

89 metastatic malignant melanoma mimicking benign breast cysts

90 autoantibodies to the ny-eso-1 tumor antigen in metastatic melanoma: sialylation of the fc region of immunoglobulin g induces differential expression signatures of inflammatory molecules during dendritic cell differentiation and maturation

91 sequential therapy with nivolumab followed by ipilimumab induces complete response in metastatic melanoma of the lung but with severe hepatotoxicities

92 immunohistochemical expression of melan-a and tyrosinase in uveal melanoma

93 stage-specific survival and recurrence in patients with cutaneous malignant melanoma in europe – a systematic review of the literature

94 cytosolic dna sensor upregulation accompanies dna electrotransfer in b16.f10 melanoma cells

95 nevus-like appearance of primary malignant melanoma of the esophagus

96 malignant melanoma of ciliary body: a case report

97 suppression of igf1r in melanoma cells by an adenovirus-mediated one-step knockdown system

98 meningeal melanomas associated with transforming ota nevus to malignant melanoma: a case report

99 incidÊncia e importÂncia do diagnÓstico precoce de melanoma no brasil

100 cellular magnetic resonance imaging: in vivo imaging of melanoma cells in lymph nodes of mice

101 hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift

Keyword Connections

Journals

Research Groups

Bibliographies